Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis

Author： Limmroth Volker   Malessa Rolf   Zettl Uwe   Koehler Jürgen   Japp Gudrun   Haller Peter   Elias Wolfgang   Obhof Winfried   Viehöver Andrea   Meier Uwe   Brosig Arne   Hasford Joerg   Putzki Norman   Kalski Gabriele   Wernsdörfer Colin  

Publisher： Springer Publishing Company

ISSN： 0340-5354

Source： Journal of Neurology, Vol.254, Iss.1, 2007-01, pp. : 67-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development of laquinimod for relapsing––remitting multiple sclerosis

By Jeffery Douglas R  

Future Neurology, Vol. 3, Iss. 6, 2008-11 ,pp. : 641-648

Future Medicine

Access to resources Recommend Favorite

Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis

By Passamonti Luca  

Brain, Vol. 132, Iss. 12, 2009-12 ,pp. : 3380-3391

Oxford University Press

Access to resources Recommend Favorite

Brain atrophy in clinically early relapsing–remitting multiple sclerosis

By Chard D.T.   Griffin C.M.   Parker G.J.M.   Kapoor R.   Thompson A.J.   Miller D.H.  

Brain, Vol. 125, Iss. 2, 2002-02 ,pp. : 327-337

Oxford University Press

Access to resources Recommend Favorite

Short-term brain volume change in relapsing–remitting multiple sclerosis

By Rovaris M.  

Brain, Vol. 124, Iss. 9, 2001-09 ,pp. : 1803-1812

Oxford University Press

Access to resources Recommend Favorite

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite